RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
  Impotence
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Impotence Channel

subscribe to Impotence newsletter
Latest Research : Urology : Impotence

   EMAIL   |   PRINT
Mechanism of erectile dysfunction in diabetes

Aug 11, 2005 - 4:55:00 PM
Increased levels of eNOS-linked O-GlcNAc were detected, and significant decreases in the levels of both Ser-1177-phosphorylated eNOS and phosphorylated Akt, the upstream mediator of eNOS phosphorylation, were observed.

 
[RxPG] Biljana Musicki et al. demonstrate that the glycosylation of endothelial nitric oxide synthase (eNOS) by the monosaccharide O-GlcNAc inhibits proper erectile function in rats with type 1 diabetes. The phosphorylation of eNOS at Ser-1177 is an important step in the promotion of tumescence.

The enzyme's activity is regulated by extracellular stimuli including electrical stimulation, shear stress, and VEGF signaling. Previous research has shown that hyperglycemia-induced O-GlcNAc modification inhibits eNOS activity in blood vessels, but the physiologic relevance of this modification in diabetic vascular tissues is unclear. Musicki et al. induced diabetes in rats and examined the penile tissues of the animals.

Increased levels of eNOS-linked O-GlcNAc were detected, and significant decreases in the levels of both Ser-1177-phosphorylated eNOS and phosphorylated Akt, the upstream mediator of eNOS phosphorylation, were observed. Although electrical stimulation increased blood flow in penile tissue of control and diabetic rats, an increase in activated eNOS in diabetic rats was not seen.

VEGF administration and shear stress were similarly ineffective in the diabetic animals, with rates of full erectile status decreased by 40%, magnitude of erectile response decreased by 30%, and tumescence rise time decreased by 70%



Publication: "Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction" by Biljana Musicki, Melissa F. Kramer, Robyn E. Becker, and Arthur L. Burnett
On the web: Full Text at Proceedings of the National Academy of Sciences 

Advertise in this space for $10 per month. Contact us today.


Related Impotence News
Smoking Increases the Risk of Erectile Dysfunction
Healthy lifestyle could fight erectile dysfunction
Erectle Dysfunction Common In Primary Care Patients
Erectile dysfunction (ED) also associated with other chronic diseases and their risk factors
Mechanism of erectile dysfunction in diabetes

Subscribe to Impotence Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)